Algorithm for treating preoperative anemia;Algoritmo para el tratamiento de la anemia preoperatoria

Revista Espanola de Anestesiologia y Reanimacion

Volumn 62, Issue S1, 2015, Pages 27-34

  Bisbe Vives, E ^a   Basora Macaya, M ^b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Erythropoietin; Hemoglobin; Intravenous iron; Perioperative anemia; Surgery

Indexed keywords

ANTIANEMIC AGENT; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; IRON;

ALGORITHM; ANEMIA; BLOOD TRANSFUSION; ELECTIVE SURGERY; HUMAN; MEDICAL ERROR; PREOPERATIVE CARE; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR; UNNECESSARY PROCEDURE;

ALGORITHMS; ANEMIA; BLOOD TRANSFUSION; ELECTIVE SURGICAL PROCEDURES; FOLIC ACID; HEMATINICS; HEMOGLOBINS; HUMANS; IRON; MEDICAL ERRORS; PREOPERATIVE CARE; RISK FACTORS; UNNECESSARY PROCEDURES; VITAMIN B 12;

EID: 84940047686     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0034-9356(15)30004-9     Document Type: Article

References (33)

1. Glance L.G., Dick A.W., Mukamel D.B., Fleming F.J., Zollo R.A., Wissler R., et al. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011, 114:283-292.
2. Wu W.C., Schifftner T.L., Henderson W.G., Eaton C.B., Poses R.M., Uttley G., et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007, 297:2481-2488.
3. Beattie W.S., Karkouti K., Wijeysundera D.N., Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009, 110:574-581.
4. Musallam K.M., Tamim H.M., Richards T., Spahn D.R., Rosendaal F.R., Habbal A., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 2011, 378:1396-1407.
5. Spahn D.R., Moch H., Hofmann A., Isbister J.P. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008, 109:951-953.
6. Shander A., Knight K., Thurer R., Adamson J., Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):S58-S69.
7. Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010, 113:482-495.
8. Bisbe E., Castillo J., Sáez M., Santiveri X., Ruiz A., Muñoz M. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective orthopedic surgery. TATM 2009, 10:166-173.
9. Bisbe E., Castillo J., Ruiz A., Santiveri X., Escolano F. Prevalencia de anemia y de alteración de los parámetros hematológicos en pacientes ancianos programados para cirugía ortopédica mayor. Anemia 2008, 1:22-30.
10. Goodnough L.T., Maniatis A., Earnshaw P., Benoni G., Beris P., Bisbe E., et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011, 106:13-22.
11. Llau J.V., Bisbe E. Transfusión y hemostasia. Un compromiso ineludible de la anestesiología moderna. Rev Esp Anestesiol Reanim 2003, 50:495-497.
12. Ganz T. Hepcidin a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788.
13. Muñoz M., García-Erce J.A., Remacha A.F. Disorders of iron metabolism. Part 1: Molecular basis of iron homeostasis. J Clin Pathol 2011, 64:281-286.
14. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
15. Leal-Noval S.R., Muñoz M., Asuero M., Contreras E., García-Erce J.A., Llau J.V., et al. Documento Sevilla de Consenso sobre Alternativas a la Transfusión de Sangre Alogénica. Actualización del Documento Sevilla. Rev Esp Anestesiol Reanim. 2013, 60:e1-e25.
16. Muñoz M., García-Erce J.A., Díez-Lobo A., Campos A., Sebastianes C., Bisbe E. Utilidad de la administración de hierro sacarosa intravenoso para la corrección de la anemia preoperatoria en pacientes programados para cirugía mayor. Med Clin (Barc) 2009, 132:303-306.
17. Bisbe E., García-Erce J.A., Díez-Lobo Muñoz M. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. Br J Anaesth 2011, 107:477-478.
18. Silvestesin S.B., Rogers G.M. Parenteral iron therapy options. Am J Hematol 2004, 76:74-78.
19. Rampton D., Folkersen J., Fishbane S., Hedenus M., Howaldt S., Locatelli F., et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014, 99:1671-1676.
20. Van Wyck D.B. Labile iron: manifestations and clinical implications. J Am Soc Nephrol 2004, 15(Suppl 2):S107-S111.
21. Chertow G.M., Mason P.D., Vaagen-Nielsen O., Ahlmen J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Trasplant 2006, 21:378-382.
22. Blazevic A., Hunze J., Boots J.M. Severe hypophosphataemia after intravenous iron administration. Neth J Med 2014, 72:50-53.
23. Muñoz M., Martín-Montáñez E. Ferric carboxymaltose for the treatment of iron-deficiency anemia. Expert Opin Pharmacother 2012, 13:907-921.
24. Litton E., Xiao J., Ho K.M. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ 2013, 347:f4822.
25. Stabler S.P. Vitamin B 12 deficiency. N Engl J Med 2013, 368:149-160.
26. Bisbe E., Sáez M., Pérez C., Castillo J., García-Erce J.A. Retraso en la mejoría de la anemia en paciente de artroplastia de cadera tratado con hierro endovenoso y epoetina alfa. Rev Esp Anestesiol Reanim 2005, 52:507-509.
27. Bisbe E., García-Erce J.A., Lamsfus J.A., Castillo J. Posibles implicaciones del déficit de vitamina B12 en el paciente quirúrgico. Rev Esp Anestesiol Reanim 2006, 53:265-266.
28. Kowalczyk M., Banach M., Mikhailidis D., Rysz J. Erythropoietin update 2011. Med Sci Monit 2011, 17:RA240-RA247.
29. Rosencher N., Poisson D., Albi A., Aperce M., Barré J., Samama C.M. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anesth 2005, 52:160-165.
30. Basora M., Colomina M.J., Tió M., Mora L., Salazar F., Ciercoles E. Optimizing preoperative haemoglobin with intravenous iron. Br J Anaesth 2013, 110:488-490.
31. Enko D., Wallner F., Von-Goedecke A., Hirschmugl C., Auersperg V., Halwachs-Baumann G. The impact of an algorithm-guided management of preoperative anemia in perioperative hemoglobin level and transfusion of major orthopedic surgery patients. Anemia 2013, 20131:641876.
32. Ferrucci L., Guralnik J.M., Bandinelli S., Semba R.D., Lauretani F., Corsi A., et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 2007, 136:849-855.
33. Henry D.H., Dahl N.V., Auerbach M.A. Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron. Am J Hematol 2011, 87:308-310.